Virax Biolabs Group Limited (VRAX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Virax Biolabs Group Limited (VRAX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $643,856, listed on NASDAQ, employing roughly 26 people, carrying a beta of 1.33 to the broader market. Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Led by James Foster, public since 2022-07-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for VRAX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →